In an effort to identify genes among the hub genes that could potentially contribute to EGFR–TKI resistance and serve as predictors of cancer progression, we conducted DFS analysis for NSCLC patients using the Kaplan–Meier plotter database. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.